CCChabier Coleman

Chabier Coleman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chabier Coleman has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of water quality, sanitation, handwashing and nutritional interventions on enteric pathogen seroconversion in rural Kenya: a cluster randomised trial

    by Henry Kanyi, Richelle W. Kihoro, Huiyu Hu, Henry Emisiko, E. Brook Goodhew, Chabier Coleman, Richelle C. Charles, Edward T. Ryan, Claire Munroe, Robert Atmar, et al.

    /Summary: Background: We evaluated whether water, sanitation, and handwashing (WASH) and nutrition interventions reduced enteric pathogen seroprevalence during the first two years of life among children in rural Kenya. Methods: We analysed the 2×2 factorial subset of the WASH Benefits Kenya cluster-randomised trial (control, WASH, nutrition, and WASH plus nutrition). Dried blood spots were collected from all children in the birth cohort after two years of intervention and at 6 and 12 months within a longitudinal substudy. Immunoglobulin G (IgG) responses were measured using a multiplex bead assay that included 12 pathogens. The primary outcome was IgG seroprevalence at 2 years. We estimated intention-to-treat differences, comparing WASH with no WASH and nutrition with no nutrition across the factorial design. Trial registration: NCT01704105 . Findings: The primary analysis included 3030 children in 384 clusters (median age 23 months). Seroprevalence increased rapidly with age and exceeded 90% for norovirus, Campylobacter , and LT-ETEC by the final visit, with several pathogens at moderate prevalences (24% were seropositive to typhoidal S. enterica HlyE). Differences between intervention groups were small: lower T. solium (−3.3 percentage points [95% CI −6.3 to −0.2]) and higher E. histolytica (3.2 [0.1 to 6.3]) with WASH versus control, and lower V. cholerae (−1.1 [−1.8 to −0.3]) and Shigella /EIEC (−2.7 [−5.5 to 0.0]) with nutrition versus no nutrition. No comparison met the 5% Benjamini– Hochberg false discovery rate threshold. Secondary analyses and age-seroprevalence curves suggested modest reductions for some pathogens but increased norovirus seroprevalence around 12 months, when intervention adherence was highest. Interpretation: At achieved adherence levels, household-level WASH and nutrition interventions were insufficient to reduce widespread early-life enteric pathogen exposure in this high-transmission setting, supporting the development of complementary vaccine and transmission-control strategies. Funding: National Institutes of Health (R01AI166671, R01AI106878, R01AI134814). The original WASH Benefits trial was funded by the Gates Foundation (OPPGD759).

  • Open Access

    Effects of water quality, sanitation, handwashing and nutritional interventions on enteric pathogen seroconversion in rural Bangladesh: a cluster randomised trial

    by Mahbubur Rahman, Pearl Anne Ante-Testard, Richelle W. Kihoro, Henry Kanyi, Henry Emisiko, Huiyu Hu, Everlyn Kamau, E. Brook Goodhew, Chabier Coleman, Shahjahan Ali, et al.

    /Summary: Background: Improvements to water quality, sanitation, handwashing (WASH) and nutrition may prevent enteric pathogen infection during the first two years of life. Few randomised controlled trials have measured pathogen-specific effects of WASH and nutritional interventions. Methods: Within a 2×2 factorial cluster-randomized trial of WASH and nutritional interventions in Bangladesh, we tested dried blood spot specimens with multiplex assay for IgG responses to 12 enteric pathogens: Norovirus , Campylobacter , LT-producing enterotoxigenic E. coli (LT-ETEC), Shigella , non-typhoidal and typhoidal Salmonella enterica , Vibrio cholerae , Cryptosporidium , Giardia , Entamoeba histolytica , Taenia solium , and Strongyloides stercoralis . Primary analysis included children with IgG measurements at ∼24 months, and secondary analysis assessed early effects in a sub-study at ∼14 months. We estimated age-specific seroprevalence and marginal seroprevalence differences for WASH and nutrition effects. Trial is registered with ClinicalTrials.gov ( NCT01590095 ). Findings: Across the four arms (450 clusters), 4817 samples were tested for IgG responses, 2453 samples at the primary endpoint. Seroprevalence increased with age, consistent with intense early-life transmission. For highest transmission pathogens, >94% of children had seroconverted to norovirus , LT-ETEC and Campylobacter by 12-18 months. WASH effects were modest and pathogen-specific but generally protective. At 24 months, children that received WASH interventions had less antibody against Shigella (–4.5%, 95% CI –7.6% to –1.5%), non-typhoidal S. enterica (–4.0%, 95% CI –6.5% to –1.5%), and Giardia (–3.4%, 95% CI –6.7% to –0.2%), although not after multiple-testing correction. Nutrition had limited effects on most enteric pathogens, but reduced non-typhoidal S. enterica at 14 months (–6.4%, 95% CI: –9.8% to –3.0%). Interpretation: Multiplex serology provided evidence that WASH may modestly reduce cumulative exposure to selected enteric pathogens, but household-level interventions were insufficient to substantially disrupt transmission in this high-exposure setting. Funding: National Institutes of Health (R01AI166671, R01AI106878, R01AI134814). The original WASH Benefits trial was funded by Gates Foundation (OPPGD759).

  • Open Access

    Use of serology to assess the probability of public health action needed for trachoma in coastal Ecuador

    by Everlyn Kamau, Lesly Simbaña Vivanco, Stuart Torres Ayala, Nikolina Walas, Gretchen Cooley, Chabier Coleman, E. Brook Goodhew, Diana L. Martin, Hadley Burroughs, Manuel Calvopiña, et al.

    We evaluated the probability of need for public health action against trachoma in Esmeraldas province, Ecuador. Compared to global references, seroconversion rates to Chlamydia trachomatis Pgp3 in children suggest high probability of action needed in rural villages (91%) and lower in more urban areas (32%), motivating further trachoma assessment.

  • Open Access

    Integrated serosurveillance to assess disease elimination in coastal Ecuador: onchocerciasis, yaws, and trachoma

    by Lesly Simbaña Vivanco, Stuart Torres Ayala, Nikolina Walas, Gretchen Cooley, Chabier Coleman, E. Brook Goodhew, Diana L. Martin, Hadley Burroughs, Everlyn Kamau, Manuel Calvopiña, et al.

    Background: Testing blood samples with multiplex bead assays can assess elimination and identify residual foci of transmission for multiple pathogens simultaneously. In Ecuador, onchocerciasis and yaws are presumed eliminated, and the status of trachoma is unknown. We assessed their elimination status by measuring IgG antibodies in children 6–24 months. Methods: In a birth cohort of 404 children measured between 2021-2024 in Esmeraldas province, Ecuador, we tested dried blood spots at ages 6, 9, 12, 18, and 24 months using a multiplex IgG assay that included antigens to Onchocerca volvulus (Ov16), Treponema pallidum (rp17, tmpa), and Chlamydia trachomatis (Pgp3, Ct694). We estimated seroprevalence and incident seroconversion rates across an urban-rural gradient. Results: Of 404 children enrolled, 370 contributed 1,606 samples. Seroprevalence was near zero for onchocerciasis (0.4%, 95% CI: 0.2% to 0.8%) and yaws (0.2%, 95% CI: 0.0% to 0.5%). Conversely, C. trachomatis Pgp3 seroprevalence increased along the urban-rural gradient from Esmeraldas city (3.4%, 95% CI: 1.8% to 5.8%) to remote, river-accessible rural villages (22.4%, 95% CI: 16.0% to 30.1%), and incident seroconversion was common in rural villages (16.1 per 100 child-years, 95% CI: 11.3 to 21.9). Conclusions: Serologic surveillance found no evidence of O. volvulus or T. pallidum transmission, consistent with elimination. High Pgp3 seroconversion rates suggest ongoing C. trachomatis transmission in rural villages. Results highlight the value of integrated serologic surveillance and motivate in-depth trachoma surveillance in Esmeraldas. Lay Summary: Antibodies measured in blood provide a sensitive measure of past infection. At the population-level, antibody responses are widely used to monitor pathogen elimination. Antibodies measured in blood samples from children along an urban-rural gradient in Ecuador showed no evidence of exposure to the pathogens that cause onchocerciasis or yaws, confirming their continued elimination in the region. However, antibody responses to chlamydia were common among children in rural villages during their first two years, motivating additional surveillance to assess trachoma endemicity in the area as its endemicity status is currently unknown. Trachoma is caused by ocular chlamydia infection, and these results indicate a need for additional surveillance to assess ocular infections and clinical signs of trachoma in this population.